neoGuardTM is now available in Kenya!

neoGuardTM is a clinical vital signs monitor designed to help provide high-quality care to patients in resource-constrained health facilities where patient loads are high and healthcare workers are stretched thin. It measures four primary vital signs and provides critical, timely data so that healthcare workers can respond rapidly and patients of all ages have the best chance to receive the care they need to survive and thrive.

neoGuard™

A 4-in-1 vital signs monitoring solution


Continuous measurement of pulse rate,
respiratory rate, SpO2, and temperature

Real-time alerts to patients in distress


Wireless, rechargeable, reusable design


Central monitoring dashboard and data analytics

Not in Kenya? Join our waitlist and we will keep you updated regarding the commercial availability of neoGuardTM.

What Sets neoGuard™ Apart?



Regulatory & Safety Information

  • neoGuard™ is undergoing CE Marking under the EU Medical Device Regulation 2017/745.
  • neoGuard™ meets the essential requirements of international medical device standards IEC 60601-1, IEC 60601-2-49, IEC 60601-1-2, and IEC 60601-1-8.
  • Neopenda is an ISO 13485 and ISO 14971 certified medical device company.

Testimonials

“We are very expectant [of neoGuard]. I tell you. It’s very good. Because most accidents that occur in the clinic come because the health worker doesn’t know… If we detect early it can be helpful”
–  Alice, community health worker, Uganda 

“This is a potential life saving product for the most vulnerable of our society”
– Sarah Shell, investor

“My baby was born early and without the help of people who were specialized she might not have made it. This will help the nurses monitor babies born early who may not have proper equipment available. It will save lives.”
– Angela K., investor

“Sometimes it is 150 babies for you alone… it makes us uneffective. It commonly encroaches on the monitoring, because by the time you start on the first baby, when you reach the last baby you may not find the last baby surviving.”
– Damalie, Senior Neonatal Nurse, Uganda

“Neopenda will provide future tools that will help fill needs in the developing world and rural environments at lower costs than are currently available. Good product!”
– Charles Riggin, investor

“I know this is going to go a long way to save the lives of newborns all over the world, most especially in developing countries with the inadequate medical staffs and types of machinery.”
– Vincent Vormawor, investor